In Vitro Diagnostics 2017
Holiday Inn Kensington Forum, London, UK (June, 14 - 15, 2017)
The third in its series, SMi is delighted to announce the return of In Vitro Diagnostics taking place in London on the 14th & 15th June 2017. Aimed at Managers/Heads and Directors of Regulatory Affairs, In Vitro Diagnostics, Clinical Affairs and Quality Assurance, IVDs 2017 will provide regulatory updates and key industry feedback from leading IVD manufacturers within this complex and ever-changing landscape.
Through a series of presentations from handpicked industry experts and Notified Bodies, the 2017 event will prepare attendees for the challenging times ahead and how to comply with regulatory requirements to ensure direct access to market ensuring the continued growing demand for use and innovation of IVDs over the next decade and beyond. Topics of discussion include: Latest updates on the IVD regulation, the changing role of notified bodies as well as the increase in requirements for clinical evidence.
Speakers include: FDA, MHRA, LNE/GMED North America, LRQA, TÜV SÜD, Ortho Clinical Diagnostics, DEKRAand many more…
Early birds available!
For details or to register, visit the website at www.in-vitro-diagnostics.co.uk/gate2biotech or contact the team at +44(0) 207827 6000, email zgale@smi-online.co.uk.
